'Spontaneous' lymphoblastoid cell lines (LCL) were established from patients with either rheumatoid arthritis (RA) or infectious mononucleosis (IM) or from healthy donors. Differences in Epstein-Barr virus (EBV) strains were determined by measuring the mol. wt. and expression of viral antigens in each of the LCLs. In addition to the previously reported EBV nuclear antigens, the LCLs also contained EBV-induced antigens with tool. wt. of 48K and 58K which were present in all but two of the lines. One of the differences observed between each of the groups of cell lines was their ability to produce viral antigens. Early and late antigens were identified by immunoblotting in most of the RA lines, two of the normal lines but none of the cell lines from patients with IM. Many of the IM cell lines were also found to express multiple EBNA1 antigens. The results demonstrate that a variety of wild-type EBV strains exist. However, the similarities observed in a number of the lines suggest that the diversity of strains may be limited.
INTRODUCTION
Epstein-Barr virus (EBV) can infect and transform B lymphocytes. For many years the only antigen that could be detected in non-productive EBV-transformed cells was the EBV nuclear antigen (EBNA) (De-The, 1980; Pearson, 1980) . With the advent of more sophisticated detection techniques a number of additional EBV-induced antigens have been identified. Using the technique of immunoblotting a second EBV-induced nuclear antigen was detected (Dambaugh et al., 1984; Sculley et al., 1984b; Strnad et al., 1981) ,and was termed EBNA2 to distinguish it from EBNA1. EBNA1 has been shown to be encoded, in part, by an internal repeat array within the EBV genome. The length of this repeat varies between different strains of EBV, consequently the mol. wt. of EBNA1 also varies between different strains of EBV (Hennessy & Kieff, 1983; Sculley et al., 1984a) . EBNA2 is encoded by a region of the genome which is required for transformation of B lymphocytes by EBV (Dambaugh et al., 1984) . Additional proteins including the latent membrane protein (LMP), which may represent a lymphocyte-determined membrane antigen (Fennewald et al., 1984) , and EBNAs 3 and 4 have also been described (Kallin et al., 1986; Hennessy et al., 1986) .
EBV is associated with several diseases in humans. It causes most heterophile-positive cases of infectious mononucleosis (IM), and is associated with Burkitt's lymphoma (BL) and nasopharyngeal carcinoma (NPC) (De-The, 1980; Pearson, 1980) . There is also some evidence linking EBV with rheumatoid arthritis (RA); sera from patients with RA have increased reactivity with EBNA2 (Sculley et al., 1984b) and B lymphocytes from RA patients show higher rates of spontaneous transformation than do normal controls (Slaughter et al., 1978) . The diversity in geographical distribution, age range, and histological characteristics of these diseases may be a reflection of different pathogenic properties of a family of closely related viruses. This concept is not new and earlier studies demonstrated EBV strain differences by measuring their ability to transform B lymphocytes and to be neutralized by various antisera (Miller et al., 1976) . Further significant differences between strains of EBV were demonstrated by measuring the number and distribution of restriction endonuclease sites within the EBV genome (Bornkamm et al., 1980; Rymo et al., 1979) . However no differences have been found that correlate with the disease of the patient from whom the strain was obtained.
Due to the lack of a fully permissive tissue culture system for propagation of EBV, only a limited number of viral strains have been extensively studied. To be able to determine effectively whether different subtypes are associated with specific diseases requires a study of viral strains in situ. This could be accomplished by establishing spontaneous EBV genomepositive lymphoblastoid cell lines (LCL) from appropriate individuals. The likelihood that the vast majority of spontaneous LCLs would not be permissive for viral replication necessitates the use of assays other than analysis of variation in viral antigenic determinants or ability to transform lymphocytes.
These constraints have been overcome by using immunoblotting to analyse EBV-encoded polypeptides expressed in spontaneous LCLs established from patients with either RA or IM or from healthy controls.
METHODS
Production of spontaneous LCLs using cyclosporin A. Unfractionated mononuclear cells from seropositive donors were seeded by doubling dilution from 2 x 106 to 1.25 × 105 cells per 0.2 ml microtitre plate well in medium containing 0.1 l.tg/ml cyclosporin A (Sandoz Ltd., Basle, Switzerland). The cyclosporin A was maintained in the media in regular refeedings for up to 8 weeks (Rickinson et al., 1984) . Each of the cell lines was grown in RPMI-1640 medium supplemented with 10 ~ foetal calf serum at 37 °C in sealed roller bottles. Cultures were harvested every 3 to 4 days and reseeded at a concentration of 5 x 105 cells per ml. Cells not used directly were collected by centrifugation and stored at -80 °C.
Study group. RA patients included in this study were attending the Rheumatology Clinic at the Princess Alexandra Hospital, Brisbane, Australia, and were categorized by a rheumatologist. Sera were obtained from patients with classical or definite RA (American Rheumatism Association criteria). Patients in the acute phase of IM were diagnosed by the Queensland University Health Service and were positive for IgM antibodies to EBV. Healthy donors were obtained from the staff at the Queensland Institute of Medical Research.
Cloning of cell lines. Cells were counted and seeded into U well microtitre plates at 1 cell per well (by cell count). After 4 h wells containing a single cell were identified using an inverted microscope, and their contents were transferred to an adherent mononuclear population, prepared from cord blood lymphocytes as previously described (Pope et al., 1974) , in fiat-bottomed microtitre wells. Growth of each clone was monitored with an inverted microscope.
EBV serology. The presence of viral capsid antigen (VCA) in cells was measured according to the method of Henle & Henle (1986) , using a known anti-VCA-positive serum. Cells were allowed to grow to approximately 1 x 106 cells per ml, then left for 48 h prior to assay. B95-8 cells were treated similarly.
Sera. Two sera were used throughout this study to identify EBNA1 and EBNA2. Serum TT was from a normal individual, had titres to EBNA (160), VCA (40), early antigen (EA) (< 10), and was known from a previous study to react only with EBNA 1 (Sculley et al., 1984b) . The second serum, RA 2, had titres to EBNA (160), VCA (160), EA (40), and reacted with both EBNAI and EBNA2 (Sculley et al., 1984b) . These sera were used at a dilution of 1:30 in immunoblots.
Preparation of whole cell lysate. Cells (1 ml packed volume) were collected by centrifugation and dispersed by sonication in 5 ml of 2~ (w/v) SDS, 1~ 2-mercaptoethanol, 0.1 mM-phenylmethylsulphonyl fluoride, 10 mMsodium phosphate (pH 6-8). The samples were then placed in a boiling water bath for 2 min, allowed to cool, and centrifuged at 15 000 g for 5 min. Samples were stored at -20 °C; 20 ~tl samples (150 ~tg of protein) were used for electrophoresis.
Polyaerylamide gel electrophoresis. Composition and electrophoresis of 5 to 15 ~ (w/v) polyacrylamide SDS slab gels were essentially as reported by Laemmli (1970) . Electrophoresis was performed at 100 V for 16 h at 0 to 4 °C.
Protein immunobtot. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose paper (BioRad) and detection of antigens with antibody and radioiodinated Protein A (70 to 100 Ci/~tg) (New England Nuclear) were performed essentially as described by Burnene (1981) , except that the transfer buffer contained 0.05 ~ SDS and the nitrocellulose sheets were blocked with 0-25 ~ gelatin solution. Samples of protein standards (Pharmacia) were iodinated by using 1251 and Iodo-Beads (Pierce Chemical, Rockford, Ill., U.S.A.). These were subjected to electrophoresis alongside cell extracts and were similarly transferred to nitrocellulose paper.
RESULTS

Cell lines from normal individuals
Seven spontaneous LCLs were generated from clinically normal individuals as described in Methods. SDS extracts were prepared from each of these lines, subjected to electrophoresis on 5 to 15~ polyacrylamide-SDS gels, then transferred to nitrocellulose papers. EBV-specific antigens were identified by incubation of the papers in either a serum (RA 2) which reacts with both EBNA1 and EBNA2 (Fig. 1 a) or a serum (TT serum) known to react only with EBNA1 ( Fig. 1 b) . All of the lines expressed both EBNA1 and EBNA2 antigens, though this was difficult to observe in the cell line depicted in lane 1 (Fig. 1 a) since both EBNA antigens exhibited similar mol. wt. One cell line also appeared to contain two EBNA1 antigens (Fig 1 b, lane 4) . The mol. wt. of EBNA1 varied from one cell line to another indicating the presence of a variety of different wild-type EBV strains in the general population. For most viruses the definition of virus strain would be based on antigenic differences between isolates, but in this case is based upon differences in the tool. wt. of the EBNA antigens so that it is possible that two similar strains by this criterion may differ in the more classical definition. The EBNA2 antigen also exhibited some variation, ranging in tool. wt. from 81K to 92K between the different lines (Table 1) . Quantification of the antigens in each of the cell lines with a laser densitometer (results not shown) revealed that in many of the lines the EBNA2 antigen appeared as either a doublet or triplet; this was most noticeable in lane 3 (Fig 1 a) . A number of higher mol. wt. antigens were also detected in each of the cell lines by the RA 2 serum. These antigens had previously been shown to be present in a variety of BL cell lines and lines established by infection in vitro of B lymphocytes with EBV (Sculley et al., 1984b) and have subsequently been characterized by Kallin et al. (1986) and Hennessy et al. (1986) . Like the EBNA1 and EBNA2 antigens, these proteins also varied between the different lines, but not only in mol. wt. and intensity but also in number. The cell lines depicted in lanes 1 and 2 expressed three of these antigens while the remaining lines exhibited only two such antigens.
Most of the cell lines also contained lower mol. wt. antigens, identified with the RA 2 serum. The cell lines depicted in lanes 1, 2 and 5 expressed an antigen with an apparent mol. wt. of 48K, and those in lanes 3 and 4 an antigen with an apparent mol. wt. of 58K. Interestingly the cell lines depicted in lanes 3 and 4 also expressed EA and VCA including a 22K late antigen component (Sculley et al., 1985) . The presence of these antigens indicated that these lines were actively producing virus. All the antigens expressed in two of the cell lines (lanes 6 and 7) exhibited almost identical mol. wt. indicating that these cell lines may have contained the same strains of virus.
Cell lines from patients with RA Spontaneous LCLs were obtained from seven patients diagnosed as having RA. Extracts from these lines were subjected to immunoblotting and antigens identified using either serum RA 2 or TT (Fig. 2) . As with the LCLs from normal donors, the variation in the mol. wt. of the EBNA1 antigen in each of the cell lines indicated that these patients were infected with different strains of virus. The antigens in two of the RA cell lines (lanes 5 and 7) exhibited marked similarities, expressing EBNA 1, EBNA2 and high mol. wt. antigens with similar mol. wt. suggesting that the lines may share the same strain of virus. All of the lines except the RA-3 line, depicted in lane 3, expressed both EBNA2 and high tool. wt. antigens. The RA-3 cell line was subjected to immunoblotting a number of times and each time neither EBNA2 nor the high tool. wt. antigens could be detected. Most of the RA lines expressed EA/VCA antigens, identified with the RA 2 serum. To quantify the percentage of cells that were producing virus each of the cell lines was examined, at two different times, by immunofluorescence ( Table 2 ). The lines were not usually positive in both tests suggesting that external factors, such as the condition of the cells or quality of foetal calf serum, influenced their ability to produce virus. This was also evident in the immunoblots where some lines, which were EA/VCA-positive by immunofluorescence, showed no indication of EA/VCA antigens. The RA lines, when positive, usually exhibited a higher percentage of virus-producing cells than that observed for the B95-8 line cultured under the same conditions. displayed marked similarities in the number and mol. wt. of the antigens expressed. None of these lines displayed E A / V C A antigens on immunoblots nor did those tested contain E A / V C A antigens by immunofluorescence ( Table 2) . Examination of the EBNA1 antigens in each of the lines revealed the expected variation in mol. wt. between the lines but with four of the lines apparently expressing multiple EBNA1 antigens (Fig 3b, lanes 1, 3, 4 and 7) . These multiple E B N A 1 antigens were also detected when three other anti-EBNA 1-positive sera Were used. The presence of these EBNA1 antigens suggested that each of these individuals may have been infected with multiple strains of virus. To determine whether this was the case or whether these particular strains of virus were capable of producing more than one type of EBNA1 antigen, the IM-7 cell line was cloned (see Methods). Analysis of each of the five IM-7 clones by immunoblotting is shown in Fig. 4 . All of the cloned lines expressed the 77K EBNA1 antigen while two of the lines also expressed the 66K EBNA1 though in differing amounts, and only one of the clones exhibited the 73K EBNA1 antigen. Quantification of the amount of each of the antigens contained in the cloned lines relative to the amount of the 77K EBNA1 component revealed a marked decrease in the amount of E B N A 2 in the clone-3 and clone-5 lines (Table 3) . DISCUSSION By examining the differences in the tool. wt. of EBV-specific antigens present in spontaneously transformed LCLs we have been able to distinguish between strains of infecting virus. Differences between virus strains were judged primarily upon the mol. wt. of EBNA1 since this antigen was easily identified us~ing TT serum. Variation in the mol. wt. of EBNA2 and the high and low mol. wt. antigens were used to distinguish between strains which expressed similar tool. wt. EBNA1 components. Using these criteria it was found that a variety of wildtype EBV strains exist in the general population. This method of analysis of virus strains only compares antigens expressed upon transformation of B lymphocytes, and cell lines containing identical EBNA antigens may contain virus strains which encode different EA/VCA components. Nevertheless the remarkable similarities observed in a number of the lines (Nor-6 and Nor-7; RA-5 and RA-7; IM-2 and IM-4) suggest that the diversity of wild-type strains may be limited.
Cell lines from patients in the acute phase of l M
One of the major differences observed between each of the groups of cell lines examined was their ability to produce virus. VCA and EA components were identified by immunoblotting in two of the cell lines from normal individuals, and six of the seven lines from patients with RA, but none of the IM cell lines. This general trend was also observed when the cell lines were analysed for VCA by immunofluorescence (Table 2) . Compared with B95-8 cells, the RA cell lines exhibited reasonably high levels of VCA-positive cells, whereas some of the cell lines from the healthy controls demonstrated similar levels to the B95-8 line and the IM lines showed no ability to produce VCA. The reasonably high levels of VCA-positive cells obtained from the RA lines might explain the relative ease with which spontaneous LCLs are established from RA patients. It is possible that the ability of LCLs to produce virus may be a reflection of the host's B cells rather than the strain of infecting virus with lines established from RA patients having initially been stimulated by various drug treatments to activate virus production in an irreversible manner and even though the established LCL is removed from this stimulation it continues to produce virus.
In addition to the previously reported EBNA antigens (EBNA1, EBNA2 and the high mol. wt. proteins) the spontaneous LCLs also contained low mol. wt. antigens. These low mol. wt. antigens exhibited apparent mol. wt. of 48K and 58K and were present in all but two (Nor-6, -7) of the LCLs. The 58K component was predominant in most of the lines which expressed EA/VCA antigens, though it is unlikely that it is a member of the EA/VCA complex since it was also expressed in two of the IM cell lines, which demonstrated no EA/VCA expression. Neither the 48K nor the 58K antigens were present in the EBV genome-negative Ramos cell line, nor were they identified with EBV seronegative sera (results not shown) indicating that they were EBV-induced. The relationship, if any, between the 48K and 58K proteins is not known. Some lines (RA-2, -4, -5 and IM-5) expressed both antigens, suggesting that they may be distinct components.
Another distinction between the different groups of cell lines was the presence of apparently multiple EBNA 1 antigens in many of the IM cell lines. The supposition that these proteins were all EBNA 1 components was based upon their detection with the TT serum. This serum has been used in studies to identify EBNA1 (Sculley et al., 1984b) in a large number of BL lines and LCLs, and in every case has reacted only with EBNA1 (and the 22K VCA antigen in virus-producing lines). Three additional sera whose reactivity was exclusively against EBNA1 and VCA also reacted with the multiple EBNA1 antigens further strengthening the concept that each of the bands represents EBNA1. It is unlikely that these EBNA1 proteins are a result of proteolysis since all cell lines were treated identically and repeat preparations of cell extracts and immunoblotting gave identical results. The presence of multiple EBNA 1 proteins in four IM cell lines implied that these individuals may have been infected with more than one strain of virus, resulting in the establishment of multiple spontaneous cell lines, each with different tool. wt. EBNA1 components. Cloning of the IM-7 cell line did not bear this out, with all of the clones expressing the 77K EBNA1 antigen. There was a differential expression of the 73K and 66K antigens, however, demonstrating the polyclonal nature of the original cell line. Quantification of the antigens expressed by the cloned lines, relative to the amount of the 77K EBNA1, revealed a marked decrease in the amount of EBNA2 and the 48K antigen in the clone-3 line and EBNA2 in the clone-5 line. That each of the cloned lines expressed the 77K EBNA1 antigen and identical mol. wt. EBNA2, high and low mol. wt. antigens (although in differing amounts), indicate that only one strain of virus was responsible for these lines but that under certain circumstances (possibly influenced by the B lymphocyte phenotype) (Brown et al., 1984) , the levels of expression of some viral antigens may be altered. The possibility that the cloned lines may contain viral genomes that have lost regions of DNA that code for either or both the 73K and 66K EBNA 1 antigens can not be discounted. Whether the expression of multiple EBNA1 antigens is unique to IM and the possible function of these antigens will have to be investigated further.
One of the most important observations made during this study was the lack of an EBNA2 antigen in the RA-3 cell line. This line was extremely difficult to establish and was not recoverable after storage in liquid nitrogen. A second line was established, again after much difficulty, from the same individual and was identical to the first with no expression of the EBNA2 antigen. Recent studies have shown that EBV can be separated into two distinct families, an A type virus which expresses EBNA2 and a B type virus which encodes a substantially different form of the antigen (Adldinger et al., 1985; Dambaugh et al., 1984; Zimber et al., 1986) . Though this line has not yet been analysed for the presence of either A or B type virus, the lack of EBNA2 expression and the fact that sera from this patient reacts with an 80K putative EBNA2 antigen in Jijoye cells (Rickinson et al., 1984) (results not shown), indicate that it may well contain a B type virus. A type strains of EBV are found worldwide whereas B type strains appear to be confined primarily to Burkitt's lymphoma cell lines derived from cases in equatorial regions of Africa (Zimber et al., 1986) . To date only two other LCLs have been found to contain B type virus and both of these are from patients with chronic IM-like disease (Rickinson, 1986 ). The presence of a possible B type virus in an individual who is not suffering from any apparent EBV-inflicted disease suggests that B type viruses may be more widespread than first thought.
This study was carried out in an attempt to determine EBV strain differences in patients with either RA or IM and normal individuals using the expression of viral antigens to distinguish between strains. With the relatively small number of cell lines examined, some interesting findings and general trends have emerged. None of the IM lines showed any indication of virus production while many of the normal and most of the RA lines exhibited some virus production. Also many of the IM lines expressed multiple EBNA1 antigens. These phenomena may be a result of the interaction of the virus and the immune system in IM and warrant further study. It is clear that strain variation is potentially important in the biology of EBV. 
